1. Aarkstore.com announces, The Latest market research report is available in
its vast collection:
ImmunoCellular Therapeutics, Ltd. – Product Pipeline Review
– 2012
You can also request for sample page of above mention reports on
sample@aarkstore.com
Summary
Global Market Direct’s pharmaceuticals report, “ImmunoCellular Therapeutics, Ltd. -
Product Pipeline Review - 2012” provides data on the ImmunoCellular
Therapeutics, Ltd.’s research and development focus. The report includes
information on current developmental pipeline, complete with latest updates, and
features on discontinued and dormant projects.
This report is built using data and information sourced from Global Markets Direct’s
proprietary databases, ImmunoCellular Therapeutics, Ltd.’s corporate website, SEC
filings, investor presentations and featured press releases, both from
ImmunoCellular Therapeutics, Ltd. and industry-specific third party sources, put
together by Global Markets Direct’s team.
Scope
- ImmunoCellular Therapeutics, Ltd. - Brief ImmunoCellular Therapeutics, Ltd.
overview including business description, key information and facts, and its locations
and subsidiaries.
- Review of current pipeline of ImmunoCellular Therapeutics, Ltd. human
therapeutic division.
2. - Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development,
including the combination treatment modalities, across the globe.
Table of contents:
List of Tables 4
List of Figures 5
ImmunoCellular Therapeutics, Ltd. Snapshot 6
ImmunoCellular Therapeutics, Ltd. Overview 6
Key Information 6
Key Facts 6
ImmunoCellular Therapeutics, Ltd. – Research and Development Overview 7
Key Therapeutic Areas 7
ImmunoCellular Therapeutics, Ltd. – Pipeline Review 9
Pipeline Products by Stage of Development 9
Pipeline Products – Monotherapy 10
ImmunoCellular Therapeutics, Ltd. – Pipeline Products Glance 11
ImmunoCellular Therapeutics, Ltd. Clinical Stage Pipeline Products 11
Phase II Products/Combination Treatment Modalities 11
ImmunoCellular Therapeutics, Ltd. – Early Stage Pipeline Products 12
Pre-Clinical Products/Combination Treatment Modalities 12
ImmunoCellular Therapeutics, Ltd. – Drug Profiles 13
ICT-037 13
Product Description 13
Mechanism of Action 13
R&D Progress 13
ICT-107 14
Product Description 14
Mechanism of Action 14
R&D Progress 14
ICT-109 16
Product Description 16
Mechanism of Action 16
R&D Progress 16
ICT-111 18
3. Product Description 18
Mechanism of Action 18
R&D Progress 18
ICT-121 19
Product Description 19
Mechanism of Action 19
List of Figures
List of Tables are also include.
For more related Reports Plz follow The link:
Product Pipeline Review – 2012
http://www.aarkstore.com/search/viewresults.asp?search=Product Pipeline
Review – 2012&PubId=&pagenum=1
ImmunoCellular Therapeutics, Ltd. – Product Pipeline Review – 2012
MannKind Corporation – Product Pipeline Review – 2012
Mundipharma International Limited – Product Pipeline Review – 2012
NewLink Genetics Corporation – Product Pipeline Review – 2012
Orexo AB – Product Pipeline Review – 2012
Paladin Labs Inc. – Product Pipeline Review – 2012
Pharmos Corporation – Product Pipeline Review – 2012
4. POZEN Inc. – Product Pipeline Review – 2012
QLT Inc. – Product Pipeline Review – 2012
Shire Plc – Product Pipeline Review – 2012
Search More Reports Related to This Category :
Pharmaceuticals and Healthcare
http://www.aarkstore.com/search/viewresults.asp?search=Pharmaceuticals and
Healthcare&PubId=&pagenum=1
For More details Plz do contact :
Aarkstore Enterprise
Lavanya
Phone:08149852585
Email: enquiry@aarkstore.com